BNF:

11.6

Status:

Grey - after consultant/specialist initiation

Decision Date:

None

Comments

GREY after consultant/specialist initiation:

• 3^rd line prostaglandin analogue (100micrograms/ml (3ml).  (Decision date - November 2015).
• 2nd line preservative free prostaglandin analogue (3ml).  Cost effective to prescribe generically.  (Decision date - July 2022).

Grey Drug Classifications

• 5: Less cost-effective than current standard therapy

search again